SERMs: Evolutionary Chemistry, Revolutionary Biology
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2089-2111
Author(s):
Chris P. Miller
Ring-Expanded (“Fat”) Nucleosides as Broad-Spectrum Anticancer and Antiviral Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
2
Page:
1093-1109
Author(s):
Ramachandra S. Hosmane
Preface
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
iii-iii
Author(s):
M. Cianfriglia
Multidrug Resistance and Cancer: The Role of the Human ABC Transporter ABCG2
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
503-511
Author(s):
Karin F. K. Ejendal and Christine A. Hrycyna
Monoclonal Antibodies as a Tool for Structure-Function Studies of the MDR1-P-Glycoprotein
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
513-530
Author(s):
M. Cianfriglia, C. Cenciarelli, S. Barca, M. Tombesi, M. Flego and M. L. Dupuis
Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1809-1814
Author(s):
Donald A. Podoloff
Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1827-1836
Author(s):
Jay Blum, Hirsch Handmaker and Neal A. Rinne
The Role of Bone Density Measurements in the Evaluation of New Treatments for Osteoporosis
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1885-1905
Author(s):
G. M. Blake and I. Fogelman
Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1707-1712
Author(s):
Ramin Altaha, Tito Fojo, Eddie Reed and Jame Abraham
Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1723-1734
Author(s):
Shazib Pervaiz